ALISO VIEJO, Calif.--Ambry Genetics, the worldwide leader in hereditary cancer testing, announced today that it has officially launched its next-generation sequencing (NGS) renal, pancreatic and paraganglioma-pheochromocytoma (PGL/PCC) hereditary cancer panels. Ambry Genetics was the first commercial laboratory to launch hereditary cancer panels using NGS in 2012 with their comprehensive BreastNext, OvaNext, ColoNext and CancerNext products. [...]

Hyderabad, India and Houston, TX, USA,: Ocimum Biosolutions announces its entry into the Core Facility Management Software space with the launch of its new product Facility Tracker™ today. This is a cloud-based, ready to use software for academic, R&D, CRO, hospitals, manufacturing, and QA&QC core facilities across various industry types. Its competitive advantages include options [...]

SAN DIEGO and IRVINE, Calif., -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, and CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics laboratory performing DNA-based testing services for developmental disorders and cancer, today jointly announced that the Sequenom Center for Molecular Medicine LLC (Sequenom CMM) and CombiMatrix [...]

Golden, Colorado -- Environmental Resource Associates (ERA), a Waters® Business, recently completed a nine-month project to significantly reduce the turnaround time for reporting laboratory proficiency testing (PT) results. Beginning August 1, ERA’s innovative new process will allow customers to know within two business days of a study close if they pass or fail a proficiency [...]

RURO and Appistry are pleased to announce their partnership to deliver integrated solutions for Big-Data Lab Management for Production-Scale NGS. Automation is a fact of life for modern labs. But effectively managing the increasingly ubiquitous handoffs between humans, instruments, and computers requires ways to expedite and support both the physical work performed in the lab [...]

Freeslate, Inc., the leading provider of high throughput research solutions, today announced updates to its Metal Impregnation System (MIPS), part of its Core Module 3 (CM3) configurable automation system for preparing, processing, and testing chemically complex samples and mixtures. Refining and chemical conversion rely on heterogeneous catalysts, chemically complex formulations with complex structures, and mechanisms [...]

SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that it has closed a registered direct offering of $15 million of common stock at a price of $7.00 per share. The shares were sold directly to an institutional investor by the Company. Trovagene intends to use the net proceeds [...]

MEDFORD, Mass.-- Hepregen Corporation, developer of next-generation HepatoPacTM and HepatoMuneTM products, announced today the appointment of Martin J. Joyce as Vice President of Finance and Administration and Chief Financial Officer. This appointment adds a highly experienced expert in finance to Hepregen’s senior management team. Mr. Joyce arrives at Hepregen as a member of Danforth Advisors [...]

CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced that the company has signed a long-term supply and exclusive licensing agreement with Novartis for immunotherapeutics involving T cells modified to express chimeric antigen receptors for the treatment of cancer. Life Technologies will provide the company's proprietary technology, Dynabeads® CD3/CD28 CTS™, which possess unique biological [...]

Siemens Healthcare Diagnostics further expanded its industry-leading clinical laboratory automation portfolio¹ by unveiling VersaCell® X3 Solution² at the 2013 AACC and ASCLS Annual Meeting and Clinical Lab Expo in Houston, July 28 – August 1 (Booth #3449). The newest model of Siemens’s longstanding VersaCell System, the new VersaCell X3 Solution now offers even more ways [...]